UBS AM’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.51M | Sell |
368,978
-9,875
| -3% | -$76.7K | ﹤0.01% | 1754 |
|
|
2025
Q4 | $2.96M | Sell |
378,853
-15,887
| -4% | -$115K | ﹤0.01% | 1719 |
|
|
2025
Q3 | $3M | Sell |
394,740
-297,229
| -43% | -$2.48M | ﹤0.01% | 1592 |
|
|
2025
Q2 | $6.2M | Buy |
691,969
+243,503
| +54% | +$2.27M | ﹤0.01% | 1602 |
|
|
2025
Q1 | $3.36M | Buy |
448,466
+47,355
| +12% | +$382K | ﹤0.01% | 1761 |
|
|
2024
Q4 | $3.02M | Buy |
401,111
+11,581
| +3% | +$87.9K | ﹤0.01% | 1846 |
|
|
2024
Q3 | $2.96M | Sell |
389,530
-43,373
| -10% | -$330K | ﹤0.01% | 1826 |
|
|
2024
Q2 | $2.68M | Buy |
432,903
+185,929
| +75% | +$1.03M | ﹤0.01% | 1838 |
|
|
2024
Q1 | $1.25M | Hold |
246,974
| – | – | ﹤0.01% | 1902 |
|
|
2023
Q4 | $1.48M | Buy |
246,974
+10,413
| +4% | +$60.3K | ﹤0.01% | 1822 |
|
|
2023
Q3 | $1.67M | Hold |
236,561
| – | – | ﹤0.01% | 1718 |
|
|
2023
Q2 | $1.97M | Hold |
236,561
| – | – | ﹤0.01% | 1649 |
|
|
2023
Q1 | $1.97M | Buy |
236,561
+32,861
| +16% | +$316K | ﹤0.01% | 1649 |
|
|
2022
Q4 | $2.34M | Sell |
203,700
-73
| -0% | -$910 | ﹤0.01% | 1461 |
|
|
2022
Q3 | $2.57M | Buy |
203,773
+3,252
| +2% | +$41.9K | ﹤0.01% | 1468 |
|
|
2022
Q2 | $2.12M | Sell |
200,521
-30,629
| -13% | -$316K | ﹤0.01% | 1592 |
|
|
2022
Q1 | $3.76M | Buy |
231,150
+26,827
| +13% | +$430K | ﹤0.01% | 1479 |
|
|
2021
Q4 | $2.83M | Buy |
204,323
+29,562
| +17% | +$391K | ﹤0.01% | 1707 |
|
|
2021
Q3 | $2.51M | Sell |
174,761
-59,132
| -25% | -$933K | ﹤0.01% | 1725 |
|
|
2021
Q2 | $3.7M | Buy |
233,893
+480
| +0.2% | +$6.52K | ﹤0.01% | 1522 |
|
|
2021
Q1 | $2.37M | Sell |
233,413
-19,212
| -8% | -$198K | ﹤0.01% | 1683 |
|
|
2020
Q4 | $1.88M | Sell |
252,625
-908,530
| -78% | -$4.68M | ﹤0.01% | 1708 |
|
|
2020
Q3 | $3.99M | Hold |
1,161,155
| – | – | ﹤0.01% | 1242 |
|
|
2020
Q2 | $5.53M | Buy |
1,161,155
+1,044,870
| +899% | +$4.17M | ﹤0.01% | 1080 |
|
|
2020
Q1 | $233K | Sell |
116,285
-11,387
| -9% | -$31.4K | ﹤0.01% | 2229 |
|
|
2019
Q4 | $440K | Buy |
127,672
+53,928
| +73% | +$136K | ﹤0.01% | 2282 |
|
|
2019
Q3 | $211K | Buy |
73,744
+7,786
| +12% | +$24.2K | ﹤0.01% | 2562 |
|
|
2019
Q2 | $250K | Buy |
65,958
+4,803
| +8% | +$28.9K | ﹤0.01% | 2470 |
|
|
2019
Q1 | $498K | Buy |
61,155
+13,126
| +27% | +$112K | ﹤0.01% | 2114 |
|
|
2018
Q4 | $388K | Hold |
48,029
| – | – | ﹤0.01% | 2108 |
|
|
2018
Q3 | $366K | Hold |
48,029
| – | – | ﹤0.01% | 2213 |
|
|
2018
Q2 | $275K | Sell |
48,029
-12,186
| -20% | -$67.1K | ﹤0.01% | 2346 |
|
|
2018
Q1 | $287K | Buy |
60,215
+18,030
| +43% | +$92.6K | ﹤0.01% | 2235 |
|
|
2017
Q4 | $207K | Hold |
42,185
| – | – | ﹤0.01% | 2302 |
|
|
2017
Q3 | $221K | Buy |
42,185
+2,442
| +6% | +$12.5K | ﹤0.01% | 2209 |
|
|
2017
Q2 | $221K | Sell |
39,743
-6,926
| -15% | -$42.2K | ﹤0.01% | 2172 |
|
|
2017
Q1 | $392K | Buy |
+46,669
| New | +$325K | ﹤0.01% | 1936 |
|
|
2016
Q4 | – | Sell |
-27,100
| Closed | -$120K | – | 2516 |
|
|
2016
Q3 | $120K | Hold |
27,100
| – | – | ﹤0.01% | 2553 |
|
|
2016
Q2 | $77K | Hold |
27,100
| – | – | ﹤0.01% | 2597 |
|
|
2016
Q1 | $77K | Sell |
27,100
-200
| -0.7% | -$886 | ﹤0.01% | 2592 |
|
|
2015
Q4 | $282K | Sell |
27,300
-2,400
| -8% | -$23.9K | ﹤0.01% | 2368 |
|
|
2015
Q3 | $339K | Buy |
29,700
+1,200
| +4% | +$16K | ﹤0.01% | 2223 |
|
|
2015
Q2 | $426K | Buy |
28,500
+2,400
| +9% | +$27.3K | ﹤0.01% | 2139 |
|
|
2015
Q1 | $236K | Buy |
26,100
+1,400
| +6% | +$14.5K | ﹤0.01% | 2399 |
|
|
2014
Q4 | $300K | Buy |
24,700
+3,100
| +14% | +$34.2K | ﹤0.01% | 2234 |
|
|
2014
Q3 | $211K | Buy |
21,600
+1,100
| +5% | +$13.5K | ﹤0.01% | 2346 |
|
|
2014
Q2 | $261K | Hold |
20,500
| – | – | ﹤0.01% | 2265 |
|
|
2014
Q1 | $217K | Hold |
20,500
| – | – | ﹤0.01% | 2386 |
|
|
2013
Q4 | $156K | Buy |
+20,500
| New | +$130K | ﹤0.01% | 2437 |
|
Other funds holding BCRX
RCM
DM
VPM
VCM
TCM
PA
VPC